Basit öğe kaydını göster

dc.contributor.authorUmar, Rashida Muhammad
dc.contributor.authorÇattık, Büşra Nur
dc.contributor.authorAslan, Selim
dc.date.accessioned2023-10-03T07:38:35Z
dc.date.available2023-10-03T07:38:35Z
dc.date.issued2023en_US
dc.identifier.citationUmar, R. M., Çattık, B. N. ve Aslan, S. (2023). Evaluation of disease and medication knowledge levels of diabetic patients. İstanbul Journal of Pharmacy, 53(2), 103-109. https://doi.org/10.26650/IstanbulJPharm.2023.1180952en_US
dc.identifier.issn2587-2087
dc.identifier.urihttps://doi.org/10.26650/IstanbulJPharm.2023.1180952
dc.identifier.urihttps://hdl.handle.net/20.500.12511/11518
dc.description.abstractBackground and Aims: Diabetes mellitus is a public health problem with a significant economic burden to society. Patient attitude is a significant determinant of adherence and clinical outcomes. We aimed to evaluate the disease and medication knowledge level of diabetic patients and possible patient-related predictive factors. Methods: Adult diabetic patients were included in the study. Patients' demographic and health-related data were collected using a pre-prepared form. Two questionnaires, KAP knowledge tool and Medication Assessment tool were used to assess the disease and medication knowledge levels of patients. Results: The mean age of 159 patients was 54.44 & PLUSMN;12.24 years. The disease and medication knowledge scores were high with an average of 13.9 & PLUSMN;1.74 and 5.26 & PLUSMN;0.53, respectively. Higher scores were linked to being male (p=0.042; p=0.007) and higher educational status (p<0.001; p=0.006). Lower scores were recorded in patients with comorbidities (p=0.002; p<0.001), older patients (p<0.001), longer disease duration (p<0.001; p=0.009), longer antidiabetic drug use (p<0.001; p=0.009) and using more drugs (p=0.002; p=0.006). None of the patients could mention any possible side effects of their medications. Conclusion: It can be deduced that patient-related factors are significant predictors of patients' disease and medication knowledge. Patient-specific education in addition to rational pharmacological intervention is necessary to achieve better clinical outcomes.en_US
dc.language.isoengen_US
dc.publisherIstanbul Universityen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectDiabetes Mellitusen_US
dc.subjectDisease Knowledgeen_US
dc.subjectMedication Knowledgeen_US
dc.subjectPatient Factorsen_US
dc.titleEvaluation of disease and medication knowledge levels of diabetic patientsen_US
dc.typearticleen_US
dc.relation.ispartofİstanbul Journal of Pharmacyen_US
dc.departmentİstanbul Medipol Üniversitesi, Eczacılık Fakültesi, Eczacılık Meslek Bilimleri Bölümü, Klinik Eczacılık Ana Bilim Dalıen_US
dc.authorid0000-0001-8902-7274en_US
dc.authorid0000-0001-8560-8450en_US
dc.authorid0000-0003-1069-7975en_US
dc.identifier.volume53en_US
dc.identifier.issue2en_US
dc.identifier.startpage103en_US
dc.identifier.endpage109en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.doi10.26650/IstanbulJPharm.2023.1180952en_US
dc.institutionauthorUmar, Rashida Muhammad
dc.institutionauthorÇattık, Büşra Nur
dc.institutionauthorAslan, Selim
dc.identifier.wos001061703800001en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster